Filing Details
- Accession Number:
- 0001562180-21-004531
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-28 17:12:26
- Reporting Period:
- 2021-06-25
- Accepted Time:
- 2021-06-28 17:12:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1459839 | Si-Bone Inc. | SIBN | Surgical & Medical Instruments & Apparatus (3841) | 262216351 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1754757 | A Karen Licitra | C/O Si-Bone, Inc. 471 El Camino Real, Suite 101 Santa Clara CA 95050 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-06-25 | 10,297 | $4.32 | 19,094 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-06-25 | 11,111 | $4.32 | 30,205 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-06-25 | 11,111 | $33.33 | 19,094 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-06-25 | 10,297 | $33.48 | 8,797 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2021-06-25 | 11,111 | $0.00 | 11,111 | $4.32 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2021-06-25 | 10,297 | $0.00 | 10,297 | $4.32 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2025-08-18 | No | 4 | M | Direct | |
| 0 | 2026-07-26 | No | 4 | M | Direct |
Footnotes
- The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $33.19 to $33.57, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnotes.
- The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $33.29 to $33.78, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnotes.
- The shares subject to the option vest in equal monthly installments over four years commencing on vesting commencement date, subject toReporting Person's continued service through each relevant vesting date.
Billionaire Hedge Funds
